US Patent Issued to Xenon Pharmaceuticals on June 3 for "Solid state crystalline forms of a selective potassium channel modulator" (Canadian Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,657, issued on June 3, was assigned to Xenon Pharmaceuticals Inc. (Burnaby, Canada).

"Solid state crystalline forms of a selective potassium channel modulator" was invented by Paul Robert Bichler (Burnaby, Canada), Jean-Jacques Alexandre Cadieux (Burnaby, Canada), Matthew David Tandy (Burnaby, Canada) and Gregory N. Beatch (Burnaby, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides solid state forms of a selective potassium channel modulator and pharmaceutical compositions comprising the solid state crystalline forms and pharmaceutically acceptable excipients, and methods for preparing and using the solid state for...